Placental Abruption after Bricanyl Injection Prior to External Cephalic Version: A Case Report

Lea Bo Sønderlund Ankerstjerne, Mohammed R Khalil

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

Breech presentation occurs in 3%-4% of all term pregnancies and an ECV is in general accepted as a safe procedure [1,2]. ECV has shown to reduce the number of Caesarean deliveries and noncephalic presentations at term [3]. Tocolysis is often used to inducing myometrial relaxation of the uterus and hereby delaying preterm delivery or facilitating successful ECV [4,5]. Tocolysis is contraindicated if placental abruption is suspected or diagnosed [6].
Placental abruption (also referred to as abruption placentae or PA) is defined as bleeding at the decidual-placental interface, which complicates approximately 0.4% to 1% of all pregnancies [7,8]. PA causes a life-threatening emergency with partial or complete placental detachment prior to delivery [8]. Therefore, early diagnosis of placental abruption is important [9]. Fetal survival depends on the severity of the abruption, gestational age and early intervention, including lateness in performing CS [9,10].
The purpose of this clinically oriented case report is to draw attention to the risk of Bricanyl and the potential association to PA.
Original languageEnglish
Article number382
JournalJournal of Pregnancy and Child Health
DOIs
Publication statusPublished - 2018

Fingerprint

Dive into the research topics of 'Placental Abruption after Bricanyl Injection Prior to External Cephalic Version: A Case Report'. Together they form a unique fingerprint.

Cite this